J-Codes
J7000–J7999: Drugs Administered Other than Oral Method
J7000–J7999
- J7030Infusion, normal saline solution , 1000 cc
- J7040Infusion, normal saline solution, sterile (500 ml = 1 unit)
- J70425% dextrose/normal saline (500 ml = 1 unit)
- J7050Infusion, normal saline solution, 250 cc
- J70605% dextrose/water (500 ml = 1 unit)
- J7070Infusion, d5w, 1000 cc
- J7100Infusion, dextran 40, 500 ml
- J7110Infusion, dextran 75, 500 ml
- J7120Ringers lactate infusion, up to 1000 cc
- J71215% dextrose in lactated ringers infusion, up to 1000 cc
- J7131Hypertonic saline solution, 1 ml
- J7165Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168Prothrombin complex concentrate human, kcentra, per i.u. of factor ix activity
- J7169Injection, coagulation factor xa recombinant, inactivated-zhzo andexxa, 10 mg
- J7170Injection, emicizumab-kxwh, 0.5 mg
- J7171Injection, adamts13, recombinant-krhn, 10 iu
- J7172Injection, marstacimab-hncq, 0.5 mg
- J7173Injection, concizumab-mtci, 0.5 mg
- J7174Injection, fitusiran, 0.04 mg
- J7175Injection, factor x, human, 1 i.u.
- J7176Injection, human fibrinogen - chmt fesilty, 1 mg
- J7177Injection, human fibrinogen concentrate fibryga, 1 mg
- J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
- J7179Injection, von willebrand factor recombinant, vonvendi, 1 i.u. vwf:rco
- J7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.
- J7181Injection, factor xiii a-subunit, recombinant, per iu
- J7182Injection, factor viii, (antihemophilic factor, recombinant), novoeight, per iu
- J7183Injection, von willebrand factor complex human, wilate, 1 i.u. vwf:rco
- J7185Injection, factor viii (antihemophilic factor, recombinant) xyntha, per i.u.
- J7186Injection, antihemophilic factor viii/von willebrand factor complex human, per factor viii i.u.
- J7187Injection, von willebrand factor complex humate-p, per iu vwf:rco
- J7188Injection, factor viii (antihemophilic factor, recombinant), obizur, per i.u.
- J7189Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
- J7190Factor viii (antihemophilic factor, human) per i.u.
- J7191Factor viii (antihemophilic factor porcine), per i.u.
- J7192Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
- J7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
- J7194Factor ix, complex, per i.u.
- J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
- J7196Injection, antithrombin recombinant, 50 i.u.
- J7197Antithrombin iii human, per i.u.
- J7198Anti-inhibitor, per i.u.
- J7199Hemophilia clotting factor, not otherwise classified
- J7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
- J7201Injection, factor ix, fc fusion protein, recombinant, alprolix, 1 i.u.
- J7202Injection, factor ix, albumin fusion protein, recombinant, idelvion, 1 i.u.
- J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 iu
- J7204Injection, factor viii, antihemophilic factor recombinant, esperoct, glycopegylated-exei, per iu
- J7205Injection, factor viii fc fusion protein recombinant, per iu
- J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
- J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, jivi, 1 i.u.
- J7209Injection, factor viii, (antihemophilic factor, recombinant), nuwiq, 1 i.u.
- J7210Injection, factor viii, (antihemophilic factor, recombinant), afstyla, 1 i.u.
- J7211Injection, factor viii, (antihemophilic factor, recombinant), kovaltry, 1 i.u.
- J7212Factor viia (antihemophilic factor, recombinant)-jncw sevenfact, 1 microgram
- J7213Injection, coagulation factor ix recombinant, ixinity, 1 i.u.
- J7214Injection, factor viii/von willebrand factor complex, recombinant altuviiio, per factor viii i.u.
- J7294Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
- J7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
- J7296Levonorgestrel-releasing intrauterine contraceptive system, kyleena, 19.5 mg
- J7297Levonorgestrel-releasing intrauterine contraceptive system liletta, 52 mg
- J7298Levonorgestrel-releasing intrauterine contraceptive system mirena, 52 mg
- J7299Intrauterine copper contraceptive miudella
- J7300Intrauterine copper contraceptive paragard
- J7301Levonorgestrel-releasing intrauterine contraceptive system skyla, 13.5 mg
- J7302Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7303Contraceptive supply, hormone containing vaginal ring, each
- J7304Contraceptive supply, hormone containing patch, each
- J7306Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309Methyl aminolevulinate mal for topical administration, 16.8%, 1 gram
- J7310Ganciclovir, 4.5 mg, long-acting implant
- J7311Injection, fluocinolone acetonide, intravitreal implant retisert, 0.01 mg
- J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313Injection, fluocinolone acetonide, intravitreal implant iluvien, 0.01 mg
- J7314Injection, fluocinolone acetonide, intravitreal implant yutiq, 0.01 mg
- J7315Mitomycin, ophthalmic, 0.2 mg
- J7316Injection, ocriplasmin, 0.125 mg
- J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
- J7320Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
- J7321Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
- J7322Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg
- J7323Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
- J7324Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
- J7325Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
- J7326Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
- J7327Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
- J7328Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
- J7329Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
- J7330Autologous cultured chondrocytes, implant
- J7331Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
- J7332Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
- J7333Hyaluronan or derivative, visco-3, for intra-articular injection, per dose
- J7335Capsaicin 8% patch, per 10 square centimeters
- J7336Capsaicin 8% patch, per square centimeter
- J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
- J7342Instillation, ciprofloxacin otic suspension, 6 mg
- J7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
- J7351Injection, bimatoprost, intracameral implant, 1 microgram
- J7352Afamelanotide implant, 1 mg
- J7353Anacaulase-bcdb, 8.8% gel, 1 gram
- J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- J7355Injection, travoprost, intracameral implant, 1 microgram
- J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
- J7401Mometasone furoate sinus implant, 10 micrograms
- J7402Mometasone furoate sinus implant, sinuva, 10 micrograms
- J7500Azathioprine, oral, 50 mg
- J7501Azathioprine, parenteral, 100 mg
- J7502Cyclosporine, oral, 100 mg
- J7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505Muromonab-cd3, parenteral, 5 mg
- J7506Prednisone, oral, per 5 mg
- J7507Tacrolimus, immediate release, oral, 1 mg
- J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509Methylprednisolone oral, per 4 mg
- J7510Prednisolone oral, per 5 mg
- J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512Prednisone, immediate release or delayed release, oral, 1 mg
- J7513Daclizumab, parenteral, 25 mg
- J7514Mycophenolate mofetil myhibbin, oral suspension, 100 mg
- J7515Cyclosporine, oral, 25 mg
- J7516Injection, cyclosporine, 250 mg
- J7517Mycophenolate mofetil, oral, 250 mg
- J7518Mycophenolic acid, oral, 180 mg
- J7519Injection, mycophenolate mofetil, 10 mg
- J7520Sirolimus, oral, 1 mg
- J7521Tacrolimus, granules, oral suspension, 0.1 mg
- J7525Tacrolimus, parenteral, 5 mg
- J7527Everolimus, oral, 0.25 mg
- J7528Mycophenolate mofetil, for suspension, oral, 100 mg
- J7599Immunosuppressive drug, not otherwise classified
- J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
- J7620Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
- J7622Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7624Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
- J7627Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
- J7628Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7631Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7632Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7633Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
- J7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
- J7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
- J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
- J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7658Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7659Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7660Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7665Mannitol, administered through an inhaler, 5 mg
- J7667Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
- J7668Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
- J7669Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7670Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7674Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
- J7676Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
- J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
- J7680Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7681Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
- J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
- J7699Noc drugs, inhalation solution administered through dme
- J7799Noc drugs, other than inhalation drugs, administered through dme
- J7999Compounded drug, not otherwise classified